Connect Biopharma Holdings Limited (CNTB) vs Pliant Therapeutics, Inc. (PLRX)
A side-by-side comparison of Connect Biopharma Holdings Limited and Pliant Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CNTB
Connect Biopharma Holdings Limited
$0.93HealthcareDelayed quote: Oct 6, 2026, 2:59 PM EDT
PLRX
Pliant Therapeutics, Inc.
$1.02HealthcareDelayed quote: Oct 6, 2026, 2:57 PM EDT
Total return — CNTB vs PLRX
growth of $100 · dividends reinvested · last 6yCNTB -95.1% (-39.6%/yr)PLRX -97.4% (-45.5%/yr)CNTB compounded faster over this window
CNTB PLRX
CNTB vs PLRX: by the numbers
- •PLRX is the larger company ($63M vs $59M market cap).
- •Both run net losses; PLRX's is the smaller (0.00% vs -86687.50% net margin).
Metrics side by side
Valuation
| Metric | CNTB | PLRX |
|---|---|---|
| P/B ratio | 2.19 | 0.43 |
Profitability
| Metric | CNTB | PLRX |
|---|---|---|
| Gross margin | 100.00% | 0.00% |
| Operating margin | -90740.62% | 0.00% |
| Net margin | -86687.50% | 0.00% |
| ROE | -132.16% | -62.81% |
| ROIC | -136.77% | -56.22% |
Growth (annualized)
| Metric | CNTB | PLRX |
|---|---|---|
| Total return CAGR (5Y) | -47.22% | -43.17% |
Frequently asked
- How have CNTB and PLRX total returns compared?
- Over the past 5 years, CNTB delivered -47.22% and PLRX delivered -43.17% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.